MAP2K7 and lung carcinoma: In this study, we demonstrated that FXS-3 could inhibit the proliferation and metastasis of lung cancer A549 cells by positively regulating JNK signaling pathways and negatively regulating ERK/p38, AKT/mTOR, and MEK/ERK signaling pathways.